Covid-19 vaccine: Don't rush to buy all logistics stocks, say analysts

As the world now awaits the vaccine to tackle the Covid-19 pandemic, most experts caution against the logistical issues for storage and transportation of the doses. Covid-19 vaccines require a precise temperature-controlled storage and complex logistics, which makes transporting them a risky business. Investors, analysts’ caution, would be better off by remaining selective and should not blanket buy logistics stocks.

Vaccine storage and transportation being a niche segment will not benefit all logistics and transportation companies, analysts say. The Pfizer vaccine, for instance, needs to be stored at minus 60 or minus 70 degree Celsius. While there are some companies